Luxfer's stock drops 10.9% to $12.22. Slow sales growth & revenue decline make it a pass despite 10.9x P/E.
Drugmakers face 100% tariffs if prices don't drop. High risk for pharma valuations!
AMAL's stock jumps 46.6% on strong EPS growth, but slowing revenue raises valuation questions.
Oil rigs rise amid Mideast tension; Brent hits $108.60 (+7.33%), WTI tops $111. Production steady.
MRVL's 108% 5-yr gain beats S&P 500. High growth, rising margins, but negative ROIC. P/E 25.9x.
Globalstar jumps 20% on Amazon buyout rumors, boosting satellite ambitions. Valuation eyed.
Oil prices surge 11% on Iran tensions, but October futures suggest a temporary disruption. S&P 500 edges up 0.11%.
Sponsored
Must Read